Welcome to LookChem.com Sign In|Join Free
  • or
Benzaldehyde, 4-(dipropylamino)-2-hydroxy- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

116450-75-0

Post Buying Request

116450-75-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

116450-75-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 116450-75-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,4,5 and 0 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 116450-75:
(8*1)+(7*1)+(6*6)+(5*4)+(4*5)+(3*0)+(2*7)+(1*5)=110
110 % 10 = 0
So 116450-75-0 is a valid CAS Registry Number.

116450-75-0Downstream Products

116450-75-0Relevant academic research and scientific papers

Effect of alkoxy side chain length on the solid-state fluorescence behaviour of bisazomethine dyes possessing dipropylamino terminal group

Yu, Hyung-Wook,Kim, Byung-Soon,Matsumoto, Shinya

, p. 131 - 139 (2017)

A study was conducted on the optical properties of alkoxy-substituted bisazomethine dyes possessing a dipropylamino terminal group in solution and the solid state. All of the derivatives had similar optical properties in chloroform solution, showing weak

Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents

Gurrapu, Shirisha,Jonnalagadda, Sravan K.,Alam, Mohammad A.,Ronayne, Conor T.,Nelson, Grady L.,Solano, Lucas N.,Lueth, Erica A.,Drewes, Lester R.,Mereddy, Venkatram R.

, p. 3282 - 3286 (2016/07/12)

Novel N,N-dialkyl carboxy coumarins have been synthesized as potential anticancer agents via inhibition of monocarboxylate transporter 1 (MCT1). These coumarin carboxylic acids have been evaluated for their in vitro MCT1 inhibition, MTT cancer cell viability, bidirectional Caco-2 cell permeability, and stability in human and liver microsomes. These results indicate that one of the lead candidate compounds 4a has good absorption, metabolic stability, and a low drug efflux ratio. Systemic toxicity studies with lead compound 4a in healthy mice demonstrate that this inhibitor is well tolerated based on zero animal mortality and normal body weight gains compared to the control group. In vivo tumor growth inhibition studies in mice show that the candidate compound 4a exhibits significant single agent activity in MCT1 expressing GL261-luc2 syngraft model but doesn't show significant activity in MCT4 expressing MDA-MB-231 xenograft model, indicating the selectivity of 4a for MCT1 expressing tumors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 116450-75-0